Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Reports Results For The Quarter Ended In December: Earnings Summary

* IRIDEX Corp  IRIX.OQ  reported a quarterly adjusted loss
of 15
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 11
cents per share.
    * Revenue rose 24% to $15.25 million from a year ago; 
analysts
expected $14.69 million. 
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IRIDEX Corp shares had fallen by 28.3% this quarter.
    * Wall Street's median 12-month price target for IRIDEX Corp
is
$9.75 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 12:26 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on IRIDEX

See all news